InsidersTradesSigma
Follow the CSPC Pharmaceutical Group Ltd. stock price and the full management transaction log of the company, a listed issuer based in Hong Kong. Shares trade on the HK market, under the oversight of HKEX. Operating in the Health Care sector, CSPC Pharmaceutical Group Ltd. has logged 6 reports. Market capitalisation: €97.4bn. The latest transaction was filed on 29 June 2026 (Sale). Among the most active insiders: Cai Dong Chen. The full history is accessible without an account.
Analysts rate CSPC Pharmaceutical Group Ltd. Buy (bullish), based on 21 analysts. Average price target: HK$11.47.
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Transparent value + quality ranking, distinct from the insider signal.
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
6 of 6 declarations
CSPC Pharmaceutical Group Ltd. es una empresa farmacéutica con sede en China dedicada a la investigación, desarrollo, fabricación y comercialización de medicamentos. Cotiza en la Bolsa de Hong Kong bajo el símbolo XHKG.